Skip to main content
. 2018 Jan 17;109(2):453–461. doi: 10.1111/cas.13464

Figure 1.

Figure 1

C‐scores of (A) BRCA1 and (B) BRCA2 variants in 283 breast and/or ovarian cancers. Deleterious mutations are indicated by black column, minor variants are indicated by gray. B, A patient with a large deletion detected by Multiplex Ligation‐dependent Probe Amplification method has no C‐score which is indicated by a star